Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4+ and CD8+ T lymphocytes are subsets of T cells—white blood cells of the adaptive immune system—with distinct functions and surface markers. CD4+ T lymphocytes (helper T cells) regulate and coordinate immune responses by secreting cytokines and instructing other immune cells, such as B lymphocytes and macrophages. CD8+ T lymphocytes (cytotoxic T cells) directly kill infected or cancerous cells by recognizing antigens presented by MHC class I molecules and inducing apoptosis. Both subsets form memory cells after activation to provide faster immune responses upon re-exposure. They are pivotal in defense against infection, surveillance against tumors, and are central drug targets in immune-modulating therapies. Dysfunction or depletion of these cells is associated with immunodeficiency (e.g., HIV), autoimmunity, cancer, and complications in transplantation[1][2][5][7].
Cell depletion (antibody mediated, immunosuppression); Checkpoint blockade (enhance cytotoxic response in cancer); Cytokine modulation (targeting interleukins that drive T cell responses); Inhibition of activation/proliferation (block T cell receptor signaling); Enhancement of immune memory (e.g., vaccines)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4+ and CD8+ T lymphocytes (CD4+ T cell, CD8+ T cell).